Wang Chunjiang, Fang Weijin, Song Liying, Deng Zhenzhen, Li Zuojun, Sun Linli
Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China.
Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, China.
Front Cardiovasc Med. 2022 Jul 11;9:901522. doi: 10.3389/fcvm.2022.901522. eCollection 2022.
Current knowledge of Kounis syndrome induced by non-steroidal anti-inflammatory drugs (NSAIDs) is based on case reports. This study aimed to investigate the clinical features of Kounis syndrome.
Case reports of the NSAIDs-induced Kounis syndrome were analyzed by searching Chinese and English databases from 1 January 1950 to 31 January 2022.
The median age of the 45 included patients (28 women) was 51 years (20-80 years). NSAIDs that were the most frequently involved were diclofenac (26.7%, 12/45), metamizole (15.6%, 7/45), and aspirin (13.3%, 6/45). Kounis syndrome occurred mainly within 30 min after administration, with a maximum latency of 1 month. Chest pain (75.6%, 34/45), dyspnea (33.3%, 15/45), and allergic reactions (44.4%, 20/45) were the most common clinical manifestations. Thirty patients (66.7%) had an ST-segment elevation on the electrocardiogram. Echocardiogram and coronary angiography showed abnormalities in 21 patients (75%, 21/28) and 15 patients (37.5%, 15/40). Forty-four patients (97.8%) had a good prognosis after treatment with steroids, antihistamines, and vasodilators.
The possibility of Kounis syndrome should be considered in the presence of coronary artery disease symptoms when taking NSAIDs. Kounis syndrome can be life-threatening. It is essential to identify and treat Kounis syndrome correctly.
目前关于非甾体抗炎药(NSAIDs)诱发的库尼斯综合征的认识基于病例报告。本研究旨在调查库尼斯综合征的临床特征。
通过检索1950年1月1日至2022年1月31日的中英文数据库,分析NSAIDs诱发库尼斯综合征的病例报告。
纳入的45例患者(28例女性)的中位年龄为51岁(20 - 80岁)。最常涉及的NSAIDs为双氯芬酸(26.7%,12/45)、安乃近(15.6%,7/45)和阿司匹林(13.3%,6/45)。库尼斯综合征主要发生在用药后30分钟内,最长潜伏期为1个月。胸痛(75.6%,34/45)、呼吸困难(33.3%,15/45)和过敏反应(44.4%,20/45)是最常见的临床表现。30例患者(66.7%)心电图出现ST段抬高。超声心动图和冠状动脉造影显示21例患者(75%,21/28)和15例患者(37.5%,15/40)存在异常。44例患者(97.8%)经类固醇、抗组胺药和血管扩张剂治疗后预后良好。
服用NSAIDs时,出现冠状动脉疾病症状时应考虑库尼斯综合征的可能性。库尼斯综合征可能危及生命。正确识别和治疗库尼斯综合征至关重要。